Nearly $2 Trillion Traded on COVID-19 Vaccine News

Nearly $2 Trillion Traded on COVID-19 Vaccine News
Small bottles labeled with "Vaccine COVID-19" stickers and a medical syringe in an illustration on April 10, 2020. Dado Ruvic/Illustration/Reuters
|Updated:

News of a breakthrough in the race to find a COVID-19 vaccine sparked one of the heaviest trading days since the height of the pandemic crisis, according to early data analyzed by Reuters, with nearly $2 trillion changing hands on Nov. 9.

Traders stampeded to the riskier plays in equities, foreign exchange, and bond markets after Pfizer Inc. released positive data on its vaccine trial, while rotating out of safe havens such as technology stocks, Japanese yen, and top-rated bonds.